Jennifer Joe, Md Email & Phone Number

Princeton, Nj, Us

Irvine, Ca, Us

Diality is a medical device company developing a smart, flexible hemodialysis platform. On August 6, 2024, we announced the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for our Moda-flx Hemodialysis System.The Moda-flx Hemodialysis System is designed to empower kidney care professionals with a wide range of variable flow rate ranges, integrated reverse osmosis water filtration, and an intuitive, easy-to-use graphical user interface. The Moda-flx Hemodialysis System provides clinicians the flexibility to easily customize each hemodialysis experience according to patient needs in one integrated system. The platform’s compact footprint and mobility enable integration and transportation within dialysis care settings.

Waltham, Ma, Us

Waltham, Ma, Us

Waltham, Ma, Us

Cambridge, Cambridgeshire, Gb

As an integral part of the Global Medical Strategy team, developed and implemented the “next generation medical affairs” strategy, with a greater emphasis on population health; payer, provider, and health system partnership; digital health; high-risk patient identification, guideline directed medical therapy, and pathway and referral optimization; data-driven metric identification and decision-making; digital communication and engagement tools; and next generation clinical trial recruitment.• Role was half global, and half United States-focused, responsible for hands-on driving implementation of high priority initiatives• Above brand and responsible for chronic kidney disease, diabetes, heart failure, hyperkalemia, asthma, chronic obstructive pulmonary disease, lupus, and amyloidosis• Deliverables included framework development, new capability prioritization and upskilling, new key performance indicator determination and implementation, and workshop development.• At 10x performance of the control, set up and delivered a top performing precision population health initiative that surpassed end-of-year goal in just the first quarter• As a key member of the ACT on Amyloidosis team, developed the global healthcare system transformation strategy with my hallmark holistic “no tech, low tech, and high tech” approach that was adopted by all priority markets within months of launch, including the United States, Canada, United Kingdom, Spain, France, Portugal, Italy, Germany, Japan, and China.

Washington, Dc, Us

Washington, Dc, Us

Washington, Dc, Us

Leopoldshöhe, North Rhine-Westphalia, De

100 employee German medical device manufacturer headquartered in Leopoldshoehe, Germany with a small suite of warming technology products used in emergency rooms, intensive care units, and surgical theaters. Worked directly with the Chief Executive Officer to lead the entry into the new cell and gene therapy manufacturing market and set up a new business entity, Barkey Corporation, to establish and develop the United States market by taking it over from a small distributer.• Stood up the US business operations with the new business entity, Barkey Corporation, including supporting the business and regulatory filings, scouting and standing up the new US business headquarters and distribution and maintenance headquarters, and hiring and training the new team of five• Fully took over all sales, marketing, implementation, and technical support activities from the local distributor and grew revenue by 3x in the first year with a book of customers over 300, which was pivotal for the company being acquired • Introduced and created new pricing structure for new products in the US market, which was pivotal for establishing higher net profit margins in the new cell and gene market• Point of contact for US regulatory bodies, including the Food and Drug Administration and the American Association of Blood Banks• Evidence generation and publication and conference planning, Principal Investigator identification Externally Sponsored Research for label expansion. Key accomplishment was achieving wider temperature safety and efficacy evidence for a key product, establishing it as the fastest in the market, pivotal for the trauma and surgery market.• Identification and management of key opinion leaders and Medical Advisory Board for the cell and gene therapy market

South Burlington, Vt, Us

• 0 to 1 of an NIH, NSF, Y-Combinator venture backed diagnostic startup where I was medical lead on developing our first product, an artificial intelligence diagnostic for COVID-19• Clinical trial, evidence generation, and publication planning, FDA filling and defending, KOL advisory board, reimbursement strategy• Led implementation in two clinical trial sites

• 0 to 1 of one the first online publication and media companies dedicated to digital health• Built three social media handles, created two annual signature events, MedTech Boston 40 Under 40 and the Google/Boston Scientific Connected Patient Challenge, both running for 5 years• Oversaw a managing editor, social media manager, and 5-15 volunteer writers

• 0 to 1 of a boot-strapped software as a service providing white-labeled online communities to healthcare, managed all the marketing, sales, business development, account management, and strategic relationships. • Led a team/startup of 10 full-time employees and 5 part-time• Led the successful exit/acquisition and integration of Medstro and MedTech Boston to the largest privately held healthcare communications company in the US.

Waltham, Ma, Us

Waltham, Ma, Us

• One of the first global second opinion companies, acquired by Teledoc• Home office clinician manager with a dedicated patient panel and supporting the management of the remote clinician managers, business development.

Research Investigator on the “Framingham Heart Study” for Black Americans. • Two hallmark publications.

Massachusetts General Hospital/Brigham And Women'S Hospital Joint Nephrology Fellowship

Internal Medicine Residency Program

Doctor Of Medicine (M.D.)

Bachelor Of Arts (B.A.), Biology/Biological Sciences, General

Education record